Company: BSX
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000885725-25-000017
Chunk: 70

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 70
---
 following table shows target award opportunities in 2024 and 2023 for our NEOs. The target award opportunities for Messrs. Brennan, Butcher, Fitzgerald and Mirviss were based on the recommendations of our CEO, internal pay equity relative to our other executives, their impact, achievement and experience in their roles and external market data.

|                      |     | Individual Target Award Opportunity 
 (As a % of Annual Base Salary)      |     |      |     |   |     |      |     |   |
| Name                 |     |                                     |     | 2023 |     |   |     | 2024 |     |   |
| Michael F. Mahoney   |     |                                     |     |      | 155 | % |     |      | 155 | % |
| Daniel J. Brennan    |     |                                     |     |      | 110 | % |     |      | 110 | % |
| Arthur C. Butcher    |     |                                     |     |      |  75 | % |     |      |  85 | % |
| Joseph M. Fitzgerald |     |                                     |     |      |  85 | % |     |      |  90 | % |
| Jeffrey B. Mirviss   |     |                                     |     |      |  75 | % |     |      |  75 | % |

After year end, individual performance is considered pursuant to the CPM process described in the Performance Considerations section above. Based on the performance assessment rating under our annual CPM process, an Individual Performance Modifier from 0% to 150% is applied to an executive’s funded ABP award to determine the

#### 2025 Proxy Statement59

### Compensation Discussion & Analysis
actual amount to be paid. Final payout for each executive may therefore range from 0% to 225% of target, as the product of the funded award under the company-wide Applicable Distribution Percentage, ranging from 0% to 150% of target, and the Individual Performance Modifier, ranging from 0% to 150%. Our NEOs had certain performance objectives intended to support our strategic imperatives, as applicable to their roles, including (i) with respect to our NEOs who support corporate functions, those aimed at driving Company-level financial performance and operational objectives; and (ii) with respect to Messrs. Butcher, Fitzgerald and Mirviss who each support a business or businesses, those aimed at supporting business-level